INHBB | Inhibin, beta B | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
IRX6 | Iroquois homeobox 6 | Transcription factors
| | | | | Tissue enhanced |
KANK4 | KN motif and ankyrin repeat domains 4 | | | | | | Tissue enhanced |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KIF25 | Kinesin family member 25 | | | | | | Tissue enhanced |
KLB | Klotho beta | Predicted membrane proteins
| | | | | Tissue enhanced |
MARC1 | Mitochondrial amidoxime reducing component 1 | Mitochondrial proteins
| | | | | Tissue enhanced |
MDFI | MyoD family inhibitor | | | | | | Tissue enhanced |
MEDAG | Mesenteric estrogen-dependent adipogenesis | | | | | | Tissue enhanced |
MINOS1-NBL1 | MINOS1-NBL1 readthrough | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MMP19 | Matrix metallopeptidase 19 | Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
MT1A | Metallothionein 1A | Cancer-related genes
| | | | | Tissue enhanced |
MYOC | Myocilin, trabecular meshwork inducible glucocorticoid response | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NMB | Neuromedin B | Predicted secreted proteins
| | | | | Tissue enhanced |
NPR1 | Natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NXNL1 | Nucleoredoxin-like 1 | | | | | | Tissue enhanced |
PALM2-AKAP2 | PALM2-AKAP2 readthrough | | | | | | Tissue enhanced |
PDE3B | Phosphodiesterase 3B, cGMP-inhibited | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PLXNA4 | Plexin A4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PPP1R1A | Protein phosphatase 1, regulatory (inhibitor) subunit 1A | | | | | | Tissue enhanced |
PRKAR2B | Protein kinase, cAMP-dependent, regulatory, type II, beta | | | | | | Tissue enhanced |
PROKR1 | Prokineticin receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PTX3 | Pentraxin 3, long | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RASL10B | RAS-like, family 10, member B | | | | | | Tissue enhanced |
RP11-599B13.6 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
SEMA3G | Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G | Predicted secreted proteins
| | | | | Tissue enhanced |
SHOX2 | Short stature homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
SLC19A3 | Solute carrier family 19 (thiamine transporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SMIM3 | Small integral membrane protein 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
SNCG | Synuclein, gamma (breast cancer-specific protein 1) | | | | | | Tissue enhanced |
SOD3 | Superoxide dismutase 3, extracellular | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SOX18 | SRY (sex determining region Y)-box 18 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
TCF15 | Transcription factor 15 (basic helix-loop-helix) | Transcription factors
| | | | | Tissue enhanced |
THRSP | Thyroid hormone responsive | | | | | | Tissue enhanced |
TMEM132C | Transmembrane protein 132C | Predicted membrane proteins
| | | | | Tissue enhanced |
TNMD | Tenomodulin | Predicted membrane proteins
| | | | | Tissue enhanced |
TNN | Tenascin N | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TWIST1 | Twist family bHLH transcription factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
TWIST2 | Twist family bHLH transcription factor 2 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
WNT11 | Wingless-type MMTV integration site family, member 11 | Predicted secreted proteins
| | | | | Tissue enhanced |